Document bB8QjnK3kZjOEmpMO9QREJnO0

To: Jennifer. B. Galvin@conocophillips.com <Jennifer. B. Galvin@conocophillips.com>; Cagen, Stuart Z SHLOIL-SHOIL-SHS <stuart.cagen@shell.com> From: michael. g. bi rd @exxonmobil.com <michael. g. bi rd @exxonmobil.com> Cc: Russell White <whiter@api.org>; Bruce Jarnot <jarnotb@api.org>; brian.e.doll@exxonmobil.com <brian.e.doll@exxonmobil.com>; stephen.m.bowes@exxonmobil.com <stephen. m. bowes@exxonmobil.com> Bcc: Received Date: 2007-08-03 18:29:06 GMT Subject: Fw: Shanghai BHRC-TC Now that the contract issues have been settled I wondered if we could get back to our previous modus operandi for the BHRC Technical Committee to have occasional but regular calls with the Pis for review and update. For instance Stuart & I had each taken the lead previously on calls with Otto & Richard respectively, with other TC members participating in these as schedules permitted. With the interdependency of the DP and CC studies in terms of data transfer it may make more sense now to have combined calls with Otto & Richard - again for purposes of update, identifying any potential hurdles and to facilitate exchange. Jennifer & Stuart if you are on board this, I would very much like to see this reimplimented. Michael Michael G. Bird, PhD., DABT Toxicology & Environmental Sciences Division, ExxonMobil Biomedical Sciences, Inc. 1545 Route 22 East P.O. Box 971 Annandale, New Jersey 08801-0971 tel: 9087301060 fax: 908 730 1199 Email: michael.g.bird@exxonmmobil.com This document and all information contained within this electronic message may be privileged, confidential and exempt from disclosure under applicable law. It is intended only for the use of the individual(s) and/or entity(ies) named above. If you are not the intended recipient, you are on notice that any unauthorized disclosure, copying, distribution, or taking of any action in reliance on the contents of the electronically transmitted materials is prohibited. SHELL-MCCLURG-064916 To: michael.g.bird@exxonmobil.com <michael.g.bird@exxonmobil.com>; Cagen, Stuart Z SHLOIL-SHOIL-SHS <stuart.cagen@shell.com> From: Galvin, Jennifer B <Jennifer.B.Galvin@conocophillips.com> Cc: Russell White <whiter@api.org>; Bruce Jarnot <jarnotb@api.org>; brian.e.doll@exxonmobil.com <brian.e.doll@exxonmobil.com>; stephen.m.bowes@exxonmobil.com <stephen. m. bowes@exxonmobil.com> Bcc: Received Date: 2007-08-0321 :31 :08 GMT Subject: RE: Shanghai BHRC-TC I don't have a problem with this starting to happen again. I think the question from the Pis will be, what is it you want us to talk about, so we just need to be prepared to answer that question. Have a good weekend everyone. Thanks, Jennifer Galvin 918-661-3865 918-662-1139 (fax) 918-519-6302 (cell) -----Original Message----From: michael.g.bird@exxonmobil.com [mailto:michael.g.bird@exxonmobil.com] Sent: Friday, August 03, 2007 1:28 PM To: Galvin, Jennifer B; stuart.cagen@shell.com Cc: Russell White; Bruce Jarnot; brian.e.doll@exxonmobil.com; stephen. m. bowes@exxonmobil.com Subject: Fw: Shanghai BHRC-TC Now that the contract issues have been settled I wondered if we could get back to our previous modus operandi for the BHRC Technical Committee to have occasional but regular calls with the Pis for review and update. For instance Stuart & I had each taken the lead previously on calls with Otto & Richard respectively, with other TC members participating in these as schedules permitted. With the interdependency of the DP and CC studies in terms of data transfer it may make more sense now to have combined calls with Otto & Richard - again for purposes of update, identifying any potential hurdles and to facilitate exchange. Jennifer & Stuart if you are on board this, I would very much like to see this reimplimented. Michael Michael G. Bird, PhD., DABT Toxicology & Environmental Sciences Division, ExxonMobil Biomedical Sciences, Inc. 1545 Route 22 East P.O. Box 971 SHELL-MCCLURG-064917 Annandale, New Jersey 08801-0971 tel: 9087301060 fax: 908 730 1199 Email: michael.g.bird@exxonmmobil.com This document and all information contained within this electronic message may be privileged, confidential and exempt from disclosure under applicable law. It is intended only for the use of the individual(s) and/or entity(ies) named above. If you are not the intended recipient, you are on notice that any unauthorized disclosure, copying, distribution, or taking of any action in reliance on the contents of the electronically transmitted materials is prohibited. SHELL-MCCLURG-064918